Dagode, Salvacion L.
HRN: 12-71-83 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CEFTAZIDIME 1GM (VIAL)
05/07/2026
05/13/2026
IV
1g
Q8h
Febrile Neutropenia
Checking Initial Appropriateness